Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지

Allelic Characterization of IGF2 and H19 Gene Polymorphisms in Molar Tissues

  • Piyamongkol, Wirawit (Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University) ;
  • Suprasert, Prapaporn (Division of Gynecologic Oncology Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University)
  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

Background: To investigate the characteristics of allelic distribution of IGF2 and H19 gene polymorphisms in molar tissues compared to normal placentas. Materials and Methods: Forty-nine specimens of molar tissues as well as 100 control normal placental tissues, delivered on the same days, were collected. Polymerase chain reaction (PCR) with restriction fragment length polymorphism (RFLP) on 2% agarose gel electrophoresis was conducted to determine the allelic distribution. The ApaI polymorphism within exon 9 of IGF2 and the RsaI polymorphism within exon 5 of H19 were employed to identify the allelic distribution of the IGF2 and H19 genes, respectively. Then the data for these genes in the molar and normal placenta tissues were compared. Results: The allelic distribution of IGF2 genes found in molar tissue were 21 (42.9%) aa (undigested), 10 (20.4%) ab (heterozygous) and 18 (36.7%) bb (digested), while in normal placenta tissue the values were 22 (22%) aa, 51 (51%) ab, and 27 (27%) bb. The allelic distribution of H19 in molar tissues was 8 (16.2%) aa (undigested), 8 (16.3%) ab (heterozygous) and 33 (67.4%) bb (digested) and in normal placental tissue was 16 (16%) aa, 36 (36%) ab and 48 (48%) bb in normal placenta tissue. These results were significantly different with P values of 0.001 and 0.037 for the allelic distribution of IGF2 and H19, respectively. Conclusions: Molar tissues showed significant differences of allelic distribution of IGF2 and H19 from normal placenta tissues.

Keywords

References

  1. Arima T, Matsuda T, Takagi N, Wake N (1997). Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet, 93, 39-47. https://doi.org/10.1016/S0165-4608(96)00221-X
  2. Ariel I, Lustig O, Oyer CE, et al (1994). Relaxation of imprinting in trophoblastic disease. Gynecol Oncol, 53, 212-9. https://doi.org/10.1006/gyno.1994.1118
  3. Biscaro A, Braga A, Berkowitz RS (2015). Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet, 37, 42-51 https://doi.org/10.1590/SO100-720320140005198
  4. Cui SJ, Tewari M, Schneider T, Rubin R (1997). Ethanol promotes cell death by inhibition of the insulin-like growth factor I receptor. Alcohol Clin Exp Res, 21, 1121-72 https://doi.org/10.1111/j.1530-0277.1997.tb04262.x
  5. Hall JG (1990) Genomic imprinting: review and relevance to human diseases. Am J Hum Genet, 46,857-73.
  6. Kolomietz E, Maire G, Nanji S,et al (2015). Placental molar disease: what are the benefits and barriers to the adoption of a comprehensive diagnostic service? Int J Gynecol Pathol, 34, 411-8. https://doi.org/10.1097/PGP.0000000000000165
  7. Kim SJ, Park SE, Lee C, et al (2003). Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases. Gynecol Oncol, 88, 411-8. https://doi.org/10.1016/S0090-8258(02)00143-9
  8. Li HW, Tsao SW, Cheung AN (2002). Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta, 23, 20-31. https://doi.org/10.1053/plac.2001.0744
  9. Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ (1993). Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet, 53, 1096-102.
  10. Steinberg KM, Schneider VA, Graves-Lindsay TA, et al (2014). Single haplotype assembly of the human genome from a hydatidiform mole. Genome Res, 24, 2066-76. https://doi.org/10.1101/gr.180893.114
  11. Zhang Y, Shields T, Crenshaw T, et al (1993) Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet, 53, 113-24.